Buys
Open market- Shares
- Avg price
- Total value
Alan J. Russell - Chief Scientific Officer, Director at Edgewise Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer, Director
- Issuer ticker
- EWTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Alan J. Russell in Edgewise Therapeutics, Inc.
Sells
Open market- Shares
- -300,000
- Avg price
- $33.31
- Total value
- -$9,993,852
Net
Past year- Shares
- -300,000
- Share %
- -100%
- Total value
- -$9,993,852
Reported holdings for Alan J. Russell in Edgewise Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer, Director
Edgewise Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 31,466
- Estimated value
- $1,398,978
- Report date
- 12 Aug 2026
- Price
- $44.46
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer, Director
Edgewise Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 32,500
- Estimated value
- $437,294
- Report date
- 12 Aug 2026
- Price
- $18.91
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Scientific Officer, Director
Edgewise Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 65,000
- Estimated value
- Report date
- 12 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Alan J. Russell in Edgewise Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.